PR

Pareshkumar Ramjibhai Dhameliya

Active Director Director DIN 08265961
DIN 08265961 First appointment Oct 2018 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Oct 2018
Shareholding value •••• Premium profile

About Pareshkumar Ramjibhai Dhameliya

Data last updated:

Pareshkumar Ramjibhai Dhameliya has 7 years in corporate governance. Holds Director role. Currently with 3 companies, including Lupitas Pharmaceuticals Private Limited and Delphard Healthcare Private Limited. Formerly with 1 company, such as Cafebeats India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹2.58 Cr; the largest is Delphard Healthcare Private Limited at ₹1.38 Cr (FY 2024).

DIN 08265961
Primary Designation Director
First Appointment 25 Oct 2018
Oldest Company Age 12 yrs
Largest company Delphard Healthcare Private Limited · ₹1.38 Cr (FY 2024)
Combined revenue ₹2.58 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Delphard Healthcare Private Limited U24303GJ2018PTC104923
Director25 Oct 20182018₹1.38 Cr (FY 2024)Active
Director04 Aug 20212014₹92.1 Lakh (FY 2025)Active
Times Vacanza Private Limited U74999GJ2016PTC093949
Director26 Mar 20212016₹27.8 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cafebeats India Private Limited U55101GJ2019PTC109056
Director11 Jul 20192019₹10.7 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lupitas Pharmaceuticals Private Limited
Delphard Healthcare Private Limited
Times Vacanza Private Limited
Cafebeats India Private Limited
Premium access

Shareholding and investment profile for Pareshkumar Ramjibhai Dhameliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pareshkumar Ramjibhai Dhameliya

Pareshkumar Ramjibhai Dhameliya has 7 years in corporate governance. Holds Director role. Currently with 3 companies, including Lupitas Pharmaceuticals Private Limited and Delphard Healthcare Private Limited. Formerly with 1 company, such as Cafebeats India Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹2.58 Cr; the largest is Delphard Healthcare Private Limited at ₹1.38 Cr (FY 2024).

Pareshkumar Ramjibhai Dhameliya is associated with 3 companies as Director, including Delphard Healthcare Private Limited (₹1.38 Cr), Lupitas Pharmaceuticals Private Limited (₹92.1 Lakh), Times Vacanza Private Limited (₹27.8 Lakh).

Pareshkumar Ramjibhai Dhameliya has expertise in General Business, Healthcare.

Pareshkumar Ramjibhai Dhameliya has 7 years in corporate governance.

By reported revenue, the largest current company of Pareshkumar Ramjibhai Dhameliya is Delphard Healthcare Private Limited, with revenue of ₹1.38 Cr (FY 2024).

The 3 current companies of Pareshkumar Ramjibhai Dhameliya that report revenue have a combined latest revenue of ₹2.58 Cr.

Pareshkumar Ramjibhai Dhameliya currently holds positions at 3 companies: Delphard Healthcare Private Limited (₹1.38 Cr), Lupitas Pharmaceuticals Private Limited (₹92.1 Lakh), Times Vacanza Private Limited (₹27.8 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available